Article Details
Retrieved on: 2021-01-22 14:26:12
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company hopes that this will give it the edge over C5 inhibitors like Alexion's Soliris and Ultomiris in paroxysmal nocturnal haemoglobinuria (PNH). “ ...
Article found on: www.evaluate.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here